Filtered By:
Infectious Disease: Endemics
Vaccination: Cervical Cancer Vaccine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 79 results found since Jan 2013.
Meeting Summary: Global Vaccine and Immunization Research Forum, 2021
Vaccine. 2023 Feb 18:S0264-410X(23)00163-9. doi: 10.1016/j.vaccine.2023.02.028. Online ahead of print.ABSTRACTThe 2021 Global Vaccine and Immunization Research Forum highlighted the considerable advances and recent progress in research and development for vaccines and immunization, critically reviewed lessons learned from COVID-19 vaccine programs, and looked ahead to opportunities for this decade. For COVID-19, decades of investments in basic and translational research, new technology platforms, and vaccines targeting prototype pathogens enabled a rapid, global response. Unprecedented global coordination and partnership h...
Source: Vaccine - February 21, 2023 Category: Allergy & Immunology Authors: Andrew Ford Angela Hwang Annie X Mo Shahida Baqar Nancy Touchette Carolyn Deal Deborah King Kristen Earle Birgitte Giersing Peter Dull B Fenton Hall Source Type: research
Impact of one and two human papillomavirus (HPV) vaccine doses on community-level HPV prevalence in South African adolescent girls: study protocol and rationale for a pragmatic before-after design
BMJ Open. 2022 Feb 10;12(2):e059968. doi: 10.1136/bmjopen-2021-059968.ABSTRACTINTRODUCTION: Vaccines against human papillomavirus (HPV) are the key to controlling cervical cancer in low/middle-income countries (LMICs) where incidence is highest, but there have been limited data from these settings on programme impact on HPV prevalence, and none in a population with endemic HIV infection. Furthermore, for many LMICs, the currently recommended two-dose schedule is difficult to deliver at scale, so there is mounting interest in a single-dose schedule.METHODS AND ANALYSIS: The Human Papillomavirus One and Two-Dose Population E...
Source: Cancer Control - February 11, 2022 Category: Cancer & Oncology Authors: Dorothy Machalek Helen Rees Admire Chikandiwa Richard Munthali Danielle Travill Zizipho Mbulawa Kathy Petoumenos Sinead Delany-Moretlwe John Kaldor HOPE Study team Source Type: research
Immunogenicity and safety of a tetravalent dengue vaccine and a bivalent HPV vaccine given concomitantly or sequentially in girls aged 9 to 14 years in Mexico
This study assessed the immunogenicity and safety of a bivalent HPV (types 16 and 18) vaccine and CYD-TDV when co-administered concomitantly or sequentially. This was a Phase IIIb, randomized, open-label, multicenter study in girls aged 9-14 years in Mexico (NCT02979535). Participants were randomized 1:1 to receive three doses of CYD-TDV 6 months apart and two doses of bivalent HPV vaccine either concomitantly with, or 1 month before (sequentially), the first 2 CYD-TDV doses. Antibody levels were measured at baseline and 28-days after each vaccine dose for all participants, using an enzyme-linked immunosorbent assay for HP...
Source: Vaccine - May 16, 2021 Category: Allergy & Immunology Authors: Jose Luis Arredondo Sandra Maria Villagomez Martinez Maria Concepcion Morales Stephanie Meyer Myew-Ling Toh Celine Zocchetti Claire Vigne Cesar Mascare ñas Source Type: research
Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018
MMWR Surveill Summ. 2021 May 14;70(3):1-26. doi: 10.15585/mmwr.ss7003a1.ABSTRACTPROBLEM/CONDITION: Adults are at risk for illness, hospitalization, disability and, in some cases, death from vaccine-preventable diseases, particularly influenza and pneumococcal disease. CDC recommends vaccinations for adults on the basis of age, health conditions, prior vaccinations, and other considerations. Updated vaccination recommendations from CDC are published annually in the U.S. Adult Immunization Schedule. Despite longstanding recommendations for use of many vaccines, vaccination coverage among U.S. adults remains low.REPORTING PER...
Source: MMWR Surveill Summ - May 13, 2021 Category: Epidemiology Authors: Peng-Jun Lu Mei-Chuan Hung Anup Srivastav Lisa A Grohskopf Miwako Kobayashi Aaron M Harris Kathleen L Dooling Lauri E Markowitz Alfonso Rodriguez-Lainz Walter W Williams Source Type: research
